Pancreatic Cancer Research

ResearcherCzech Academy of Sciences, Institute of BiotechnologyNo recent work listed

Ladislav Anděra

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3073-2280; OpenAlex author ID A5082643230. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper

Papers 2

  1. TRAIL induces apoptosis but not necroptosis in colorectal and pancreatic cancer cells preferentially via the TRAIL-R2/DR5 receptor. Last author DOI 10.1016/j.bbamcr.2017.12.006↗
  2. Emetine enhances the tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of pancreatic cancer cells by downregulation of myeloid cell leu… Co-author DOI 10.3892/or.2013.2838↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jiřı́ Neužil · 1 shared paper, 2018 · strength 0.09
  2. Zuzana Nahácka · 1 shared paper, 2018 · strength 0.09
  3. Yujeong Han · 1 shared paper, 2014 · strength 0.05
  4. Inki Kim · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.